PDS Biotechnology Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2014 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: PDS Biotechnology Corp annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2014 to Q4 2022.
PDS Biotechnology Corp Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $1.37M, a 17.9% decline year-over-year.
PDS Biotechnology Corp Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $5.2M, a 27.5% increase year-over-year.
PDS Biotechnology Corp annual Share-based Payment Arrangement, Expense for 2023 was $7.61M, a 46.5% increase from 2022.
PDS Biotechnology Corp annual Share-based Payment Arrangement, Expense for 2022 was $5.2M, a 27.5% increase from 2021.
PDS Biotechnology Corp annual Share-based Payment Arrangement, Expense for 2021 was $4.07M, a 842% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2022	$5.2M	$1.37M	-$299K	-17.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$5.5M	$1.34M	-$357K	-21%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$5.85M	$1.35M	+$907K	+205%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$4.95M	$1.13M	+$871K	+338%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$4.07M	$1.67M	+$1.54M	+1173%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-28
Q3 2021	$2.53M	$1.7M	+$1.57M	+1211%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$960K	$442K	+$395K	+858%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$565K	$258K	+$133K	+106%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$432K	$131K	-$114K	-46.4%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	$546K	$130K	+$9.59K	+7.98%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$537K	$46.1K	+$27.5K	+148%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$509K	$125K	-$2.63M	-95.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	$3.14M	$245K	+$86.8K	+54.7%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-18
Q3 2019	$3.05M	$120K	+$78.5K	+188%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-13
Q2 2019	$2.97M	$18.6K	-$26K	-58.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	$3M	$2.75M	+$2.75M	+39171%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-13
Q4 2018	$252K	$159K	-$1.39M	-89.7%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-27
Q3 2018	$1.64M	$41.7K	-$1.53M	-97.3%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	$3.17M	$44.6K	-$1.54M	-97.2%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-01
Q1 2018	$4.7M	$7.02K	-$1.48M	-99.5%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q4 2017	$6.18M	$1.55M	+$270K	+21.2%	Oct 1, 2017	Dec 31, 2017	10-K	2019-02-21
Q3 2017	$5.91M	$1.57M	+$338K	+27.4%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-01
Q2 2017	$5.58M	$1.58M	+$200K	+14.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-01
Q1 2017	$5.38M	$1.49M	+$70.4K	+4.97%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-01
Q4 2016	$5.31M	$1.28M	-$57K	-4.28%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-01
Q3 2016	$5.36M	$1.23M	+$621K	+102%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-01
Q2 2016	$4.74M	$1.38M	+$797K	+137%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-01
Q1 2016	$3.94M	$1.42M	+$1.04M	+281%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-03
Q4 2015	$2.9M	$1.33M			Oct 1, 2015	Dec 31, 2015	10-K	2018-03-01
Q3 2015		$612K	+$332K	+119%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-01
Q2 2015		$584K			Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-03
Q1 2015		$371K			Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-03
Q3 2014		$280K			Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.